Award recordCONTRACT

MYRIAD GENETIC LABORATORIES INC

PIID VA248P1141· VHA· 673-TAMPA· Q301 · MEDICAL- LABORATORY TESTING· FY2009· $312,436 net obligations· UEI H7C7T3D6ZSB8· UT

Description

OTHER FUNCTIONS. GENETIC BRACANALYSIS TESTING FOR ASSESSMENT OF HEREDITARY RISK OF BREAST CANCER.

Base award description: GENETIC BRACANALYSIS TESTING FOR ASSESSMENT OF HEREDITARY RISK OF BREAST CANCER.

First action · last action
2009-07-01 · 2012-03-27
Transactions
4
First transaction's obligation
$106,704
Base + all options value (sum of deltas)
$462,232
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621511 · MEDICAL LABORATORIES

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$312,436$0Base award · 2009-07-01 · this action $106,704 · running total $106,704Modification 1 · 2010-05-20 · this action $142,272 · running total $248,976Modification 2 · 2011-07-01 · this action $38,076 · running total $287,052Modification 3 · 2012-03-27 · this action $25,384 · running total $312,436
  • Base2009-07-01+$106,704= $106,704
  • Mod 12010-05-20+$142,272= $248,976
  • Mod 22011-07-01+$38,076= $287,052
  • Mod 32012-03-27+$25,384= $312,436
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2009-07-01+$106,704$106,704GENETIC BRACANALYSIS TESTING FOR ASSESSMENT OF HEREDITARY RISK OF BREAST CANCER.
Mod 1· EXERCISE AN OPTION2010-05-20+$142,272$248,976GENETIC BRACANALYSIS TESTING FOR ASSESSMENT OF HEREDITARY RISK OF BREAST CANCER.
Mod 2· EXERCISE AN OPTION2011-07-01+$38,076$287,052GENETIC BRACANALYSIS TESTING FOR ASSESSMENT OF HEREDITARY RISK OF BREAST CANCER.
Mod 3· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2012-03-27+$25,384$312,436OTHER FUNCTIONS. GENETIC BRACANALYSIS TESTING FOR ASSESSMENT OF HEREDITARY RISK OF BREAST CANCER.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H7C7T3D6ZSB8)

AwardOffice · PSC / listingNet obligationsFY
36C25925N0118NETWORK CONTRACT OFFICE 19 (36C259) · Q301 · REFERENCE LABORATORY TESTING$14,994FY2025
36C25225N0120252-NETWORK CONTRACT OFFICE 12 (36C252) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE$5,984FY2025
36C25924N0251NETWORK CONTRACT OFFICE 19 (36C259) · Q301 · MEDICAL- LABORATORY TESTING$14,994FY2024
36C25224N0196252-NETWORK CONTRACT OFFICE 12 (36C252) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE$2,992FY2024
36C25923N0246NETWORK CONTRACT OFFICE 19 (36C259) · Q301 · REFERENCE LABORATORY TESTING$2,499FY2023
36C25223N0191252-NETWORK CONTRACT OFFICE 12 (36C252) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE$10,982FY2023

Other recipients under Q301 from 673-TAMPA (most recent first)

AwardRecipientOfficeNet obligationsFY
VA673C20023IRIS INTERNATIONAL, INC.673-TAMPA$50,436FY2012
VA673C20020UNIVERSITY OF SOUTH FLORIDA673-TAMPA$69,730FY2012
VA673C20022EUROFINS VIRACOR, LLC673-TAMPA$44,269FY2012
VA248P1797ONEBLOOD, INC673-TAMPA$1,008,912FY2011
VA673C10136ARUP LABORATORIES INC673-TAMPA$83,686FY2011

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA248P1141_3600_-NONE-_-NONE- · retrieved 2026-09-26.